Novus Cannabis MedPlan, traded as Novus Acquisition and Development Corp., demonstrated robust financial performance in Q3 2025 with notable revenue and EBITDA growth. The company's commitment to non-dilutive capital strategy, self-funding market initiatives, and expanding its Provider and Health Plan Network contributed to its success. Novus's focus on maintaining a strong balance sheet, capital structure integrity, and innovative approach in combining online pharmacy prescription drug plans with Savings Accounts and Flexible Spending Accounts sets them apart in the market.